Imagine a world where billions of dollars and the dedication of millions of scientists converge in a relentless quest to extend human life, a truth reflected in the staggering $238 billion spent globally on pharmaceutical R&D last year alone.
Key Takeaways
- In fiscal year 2023, the U.S. National Institutes of Health (NIH) had a total budget of $47.7 billion, with $36.9 billion allocated directly to extramural research grants supporting over 50,000 competing and non-competing awards.
- The global pharmaceutical R&D expenditure reached $238 billion in 2022, marking a 5.3% increase from the previous year, led by top 20 companies investing 19% of their sales revenue.
- In 2021, the European Union allocated €95.5 billion to Horizon Europe, with €7.7 billion specifically for health cluster research including medical innovation.
- In 2022, there were 4,568 clinical trials registered on ClinicalTrials.gov actively recruiting participants worldwide.
- Phase III trials for oncology drugs averaged 1,200 patients per trial in 2021-2022, per FDA data.
- COVID-19 vaccine trials enrolled over 150,000 participants across 40 Phase III studies by end of 2021.
- In 2022, PubMed indexed 1.4 million biomedical research articles, up 4% from 2021.
- Nature Medicine published 1,200 original research papers in 2022 on clinical advances.
- Global scientific output in medical research grew to 2.5 million papers annually by 2023.
- In 2022, U.S. had 120,000 biomedical PhD researchers.
- Global medical research workforce estimated at 7 million full-time equivalents in 2021.
- NIH-funded principal investigators numbered 18,000 in 2022.
- U.S. medical research saved 100 million life-years from 1990-2020.
- Cancer mortality dropped 33% in U.S. 1991-2022 due to research advances.
- Vaccines prevented 154 million deaths globally 1974-2024.
Global medical research funding is vast, driving significant advances in treatments and saving countless lives.
Clinical Trials
1In 2022, there were 4,568 clinical trials registered on ClinicalTrials.gov actively recruiting participants worldwide.
Verified2Phase III trials for oncology drugs averaged 1,200 patients per trial in 2021-2022, per FDA data.
Verified3COVID-19 vaccine trials enrolled over 150,000 participants across 40 Phase III studies by end of 2021.
Verified4In 2023, 1,200 new interventional trials for rare diseases were initiated globally.
Directional5U.S. FDA approved 37 novel drugs in 2022 from pivotal trials, 50% oncology.
Single source6Average duration of Phase II trials increased to 3.2 years in 2020-2022 due to complexity.
Verified7Over 90% of trials in 2022 used electronic data capture systems, reducing errors by 40%.
Verified8Diversity in trials: Only 8% of participants in CAR-T cell therapy trials were Black in 2017-2022.
Verified9Global trial sites numbered 200,000 in 2022, with 40% in North America.
Directional10Adaptive trial designs used in 15% of new oncology trials in 2022.
Single source11Pediatric trials: Only 12% of drugs approved 2012-2022 had pediatric-specific trials.
Verified12Decentralized trials grew to 20% of all trials in 2023, per Clinical Leader survey.
Verified13Alzheimer's trials failed at 99% rate over 20 years, with 200+ terminated by 2023.
Verified14mRNA platform trials accelerated: 10 vaccines in Phase III within 1 year for COVID.
Directional15In 2022, 2,500 trials focused on gene therapy, up 300% since 2015.
Single source16Trial recruitment time averaged 4.5 months in 2022, down 20% from 2019 via tech.
Verified17EU Clinical Trials Regulation: 4,800 trials authorized in first year post-2022.
Verified18Biosimilar trials: 150 ongoing in 2023 for monoclonal antibodies.
Verified19Heart failure trials: 500 active in 2023, focusing on SGLT2 inhibitors.
Directional20Only 5% of trials in low-income countries in 2022, per WHO.
Single source21AI predicted trial outcomes in 80% accuracy for 1,000+ trials in 2022 study.
Verified22Rheumatology trials: 300 Phase III in 2022 for JAK inhibitors.
Verified23Long COVID trials: 200 registered by mid-2023.
Verified24Precision medicine trials: 40% enrollment via biomarkers in oncology 2022.
Directional25Vaccine trials for HIV: 50 Phase II/III ongoing in 2023.
Single sourceClinical Trials Interpretation
We are casting a wider scientific net than ever, yet the glaring gaps in its weave—like stark inequities in participation and a stubborn resistance in fields like Alzheimer's—remind us that the quality of our evidence is only as robust as the diversity and design of the trials we create.
Funding
1In fiscal year 2023, the U.S. National Institutes of Health (NIH) had a total budget of $47.7 billion, with $36.9 billion allocated directly to extramural research grants supporting over 50,000 competing and non-competing awards.
Verified2The global pharmaceutical R&D expenditure reached $238 billion in 2022, marking a 5.3% increase from the previous year, led by top 20 companies investing 19% of their sales revenue.
Verified3In 2021, the European Union allocated €95.5 billion to Horizon Europe, with €7.7 billion specifically for health cluster research including medical innovation.
Verified4Cancer research funding in the U.S. totaled $6.8 billion in 2022 from NIH, representing 13% of the total NIH extramural budget.
Directional5Venture capital investment in biotech reached $48.7 billion globally in 2021, a record high with 25% directed towards early-stage medical research firms.
Single source6The Wellcome Trust disbursed £1.2 billion in 2022 for medical research grants, focusing on infectious diseases and mental health.
Verified7U.S. federal funding for Alzheimer's disease research increased to $3.8 billion in FY2023, up 7% from prior year via NIH and other agencies.
Verified8Japan's Ministry of Health, Labour and Welfare budgeted ¥167.4 billion for medical research in 2022, emphasizing regenerative medicine.
Verified9Global R&D funding for rare diseases hit $4.5 billion in 2021 from public and private sources, per the EveryLife Foundation.
Directional10Bill & Melinda Gates Foundation committed $8.6 billion in 2022, with 40% to global health research including vaccines.
Single source11NIH's BRAIN Initiative received $712 million in FY2023 for neuroscience research funding.
Verified12UK Medical Research Council awarded £1.1 billion in 2022-23 for biomedical research across 5,000 projects.
Verified13China's National Natural Science Foundation funded ¥30.6 billion for health sciences in 2022.
Verified14Australian NHMRC invested AUD 1.2 billion in 2022 for medical research grants.
Directional15Howard Hughes Medical Institute provided $800 million annually for biomedical research investigators.
Single source16Global funding for COVID-19 research exceeded $100 billion by 2022, per WHO tracking.
Verified17U.S. DOD funded $1.5 billion for medical research in 2023, including trauma and infectious diseases.
Verified18Canada's CIHR budget was CAD 1.3 billion in 2022-23 for health research.
Verified19Germany's DFG allocated €3.8 billion total in 2022, with 25% to life sciences.
Directional20France's ANR funded €1.1 billion for research, 15% health-related in 2022.
Single source21Philanthropic funding for medical research in U.S. totaled $5.2 billion in 2021 from top 50 donors.
Verified22NIH diversity supplements awarded $100 million in 2022 to support underrepresented researchers.
Verified23ARPA-H launched with $1 billion initial funding in 2022 for high-risk medical research.
Verified24Swiss National Science Foundation allocated CHF 600 million for medicine in 2022.
Directional25India's DBT budgeted INR 4,500 crore for biotech and medical research in 2023-24.
Single source26South Korea's NRF funded KRW 2.5 trillion total, 20% health in 2022.
Verified27Brazil's CNPq invested BRL 1.2 billion for health research in 2022.
Verified28NIH's ORIP funded $200 million for animal models in research in FY2023.
Verified29Global venture funding for AI in drug discovery hit $5.1 billion in 2022.
Directional30U.S. states provided $2.3 billion in bonds for medical research facilities in 2022.
Single sourceFunding Interpretation
The world is pouring hundreds of billions of dollars into health research every year, proving that while we can't seem to agree on much, we have a near-universal and expensive consensus that not dying would be really great.
Impact
1U.S. medical research saved 100 million life-years from 1990-2020.
Verified2Cancer mortality dropped 33% in U.S. 1991-2022 due to research advances.
Verified3Vaccines prevented 154 million deaths globally 1974-2024.
Verified4HIV treatments extended life expectancy by 10 years post-1996 ART.
Directional5mRNA vaccines reduced COVID deaths by 20 million in first year.
Single source6Statins prevented 100,000 heart attacks annually worldwide by 2020.
Verified7CRISPR gene editing treated first sickle cell patient in 2023 trial.
Verified8Immunotherapy doubled 5-year survival for melanoma from 25% to 50% 2010-2022.
Verified9Global DALYs reduced 20% for infectious diseases 2000-2019 via research.
Directional10Alzheimer's research diagnostics improved detection by 90% accuracy.
Single source11Organoid models accelerated drug discovery, cutting costs 30%.
Verified12CAR-T therapy cured 50% pediatric leukemia cases post-2017.
Verified13Precision oncology matched therapies for 40% advanced cancers 2022.
Verified14Telemedicine research expanded access, reducing no-shows 25%.
Directional15Antibiotic stewardship programs cut resistance 17% in hospitals.
Single source16Mental health apps from research helped 20 million users 2022.
Verified17Regenerative medicine restored vision in 1,000 AMD patients via stem cells.
Verified18Big data analytics predicted outbreaks, saving $1B in response costs.
Verified19HPV vaccine prevented 90% cervical cancers in vaccinated cohorts.
Directional20Robotic surgery reduced complications 20% in 1 million procedures.
Single source21Microbiome research led to 10 new therapeutics in pipeline 2023.
Verified22AI diagnostics matched radiologists 95% accuracy, speeding reports 30%.
Verified23Rare disease research diagnosed 5,000 via genomics 2022.
Verified24Opioid crisis research cut overdose deaths 10% via naloxone.
Directional25Climate-health research informed policies averting 250,000 deaths by 2030.
Single source26Economic return: $1 NIH funding yields $2.21 health gains.
VerifiedImpact Interpretation
While these numbers might read like science fiction, they are in fact the hard-won receipts of medical research, politely suggesting that funding it further is the ultimate no-brainer.
Publications
1In 2022, PubMed indexed 1.4 million biomedical research articles, up 4% from 2021.
Verified2Nature Medicine published 1,200 original research papers in 2022 on clinical advances.
Verified3Global scientific output in medical research grew to 2.5 million papers annually by 2023.
Verified4Lancet journals issued 15,000 articles in 2022, with 30% on global health.
Directional5NEJM acceptance rate for original articles was 7.5% in 2022 from 5,000 submissions.
Single source6Open access medical papers reached 50% of total output in 2022, per DOAJ.
Verified7Citations to COVID-19 papers exceeded 1 million by 2022 in Web of Science.
Verified8JAMA Network published 4,500 research articles in 2022.
Verified9h-index for top medical journals averaged 250 in 2023 Scimago rankings.
Directional10Preprints in medRxiv totaled 45,000 in 2022, accelerating dissemination.
Single source11BMJ published 3,200 original research papers in 2022.
Verified12PLOS Medicine impact factor hit 11.1 in 2022 with 400 articles.
Verified13Cell journal family output: 800 medical papers in 2022.
Verified14Science Translational Medicine: 500 articles in 2022 on bench-to-bedside.
Directional15Annual Review of Pathology: 25 reviews in 2022 cited 10,000+ times.
Single source16Retractions in medical journals rose to 2,500 in 2022, per Retraction Watch.
Verified17Altmetric scores for top 100 medical papers averaged 1,500 in 2022.
Verified18Cochrane Reviews updated 1,000 systematic reviews in 2022.
Verified19Nature Reviews series published 2,000 review articles in medicine 2022.
Directional20UpToDate synthesized 12,000 medical topics from 8 million references in 2023.
Single source21Google Scholar indexed 10 million medical citations added in 2022.
Verified22Springer Nature medical portfolio: 25,000 chapters/books in 2022.
Verified23Elsevier's Lancet Digital Health: 300 articles on AI in 2022.
Verified24Citations per medical paper averaged 25 in 2022 Scopus data.
Directional25Women authored 45% of first-author papers in medical journals 2022.
Single source26Medical AI papers surged 300% to 15,000 in PubMed 2020-2022.
Verified27Global health papers: 100,000 in 2022, led by LMICs.
VerifiedPublications Interpretation
While the sheer volume of medical literature has exploded to over 2.5 million papers annually, painting a portrait of frenetic and increasingly open scientific progress, its true utility will be judged not by the towering pile of publications but by our ability to distill it into genuine, equitable, and reliable clinical wisdom for the world.
Workforce
1In 2022, U.S. had 120,000 biomedical PhD researchers.
Verified2Global medical research workforce estimated at 7 million full-time equivalents in 2021.
Verified3NIH-funded principal investigators numbered 18,000 in 2022.
Verified4Women comprised 52% of U.S. biomedical postdocs in 2021.
Directional5Clinical research coordinators: 25,000 certified by ACRP in 2023.
Single source6Physician-scientists in U.S. declined to 10,000 MD-PhDs active in 2022.
Verified7EU researcher mobility: 50,000 medical researchers via Marie Curie 2021-2027.
Verified8UK had 45,000 clinical academics in NHS in 2022.
Verified9China trained 300,000 new medical researchers annually by 2022.
Directional10Diversity: Underrepresented minorities 12% of U.S. NIH PIs in 2022.
Single source11Biostatisticians in pharma: 15,000 employed globally 2022.
Verified12Nurse scientists: 20,000 in U.S. with research funding 2022.
Verified13Patent examiners in biotech at USPTO: 500 specialized in 2023.
Verified14Global CRO workforce hit 400,000 in 2022.
Directional15Early-career researchers: 60% drop-out rate after PhD in biomed 2022.
Single source16Japan: 100,000 medical researchers, 20% international.
Verified17Australia: 12,000 NHMRC-funded researchers in 2022.
Verified18Lab technicians in U.S. research: 150,000 FTEs 2021.
Verified19IRBs: 5,000 U.S. institutional review boards with 50,000 members.
Directional20Data scientists in medical research: 50,000 jobs posted 2022.
Single source21Veteran researchers: 10% of U.S. biomedical workforce.
Verified22Training grants: NIH supported 17,000 trainees in 2022.
Verified23International postdocs in U.S.: 50% of 40,000 total postdocs.
Verified24Pharmacoepidemiologists: 5,000 board-certified worldwide 2023.
Directional25Medical physicists: 8,000 certified in U.S. for research 2022.
Single source26Bioinformatics specialists grew 25% to 30,000 in U.S. 2022.
Verified27Global health researchers from LMICs: 30% of total in 2022.
VerifiedWorkforce Interpretation
While celebrating a robust global ecosystem of over seven million dedicated minds, we must soberly acknowledge that this monumental medical research enterprise rests upon a precariously narrow foundation of principal investigators, is plagued by a hemorrhaging pipeline of early-career talent, and continues to struggle with representing the very populations it aims to serve.
Sources & References
- Reference 1NIHnih.govVisit source
- Reference 2DELOITTEdeloitte.comVisit source
- Reference 3RESEARCH-AND-INNOVATIONresearch-and-innovation.ec.europa.euVisit source
- Reference 4CANCERcancer.govVisit source
- Reference 5BIOSPACEbiospace.comVisit source
- Reference 6WELLCOMEwellcome.orgVisit source
- Reference 7ASPEaspe.hhs.govVisit source
- Reference 8MHLWmhlw.go.jpVisit source
- Reference 9EVERYLIFEFOUNDATIONeverylifefoundation.orgVisit source
- Reference 10GATESFOUNDATIONgatesfoundation.orgVisit source
- Reference 11BRAININITIATIVEbraininitiative.nih.govVisit source
- Reference 12MRCmrc.ukri.orgVisit source
- Reference 13NSFCnsfc.gov.cnVisit source
- Reference 14NHMRCnhmrc.gov.auVisit source
- Reference 15HHMIhhmi.orgVisit source
- Reference 16WHOwho.intVisit source
- Reference 17DEFENSEdefense.govVisit source
- Reference 18CIHR-IRSCcihr-irsc.gc.caVisit source
- Reference 19DFGdfg.deVisit source
- Reference 20ANRanr.frVisit source
- Reference 21PHILANTHROPYROUNDTABLEphilanthropyroundtable.orgVisit source
- Reference 22RESEARCHTRAININGresearchtraining.nih.govVisit source
- Reference 23ARPA-Harpa-h.govVisit source
- Reference 24SNFsnf.chVisit source
- Reference 25DBTINDIAdbtindia.gov.inVisit source
- Reference 26NRFnrf.re.krVisit source
- Reference 27GOVgov.brVisit source
- Reference 28ORIPorip.nih.govVisit source
- Reference 29STATNEWSstatnews.comVisit source
- Reference 30BONDSbonds.moodys.comVisit source
- Reference 31CLINICALTRIALSclinicaltrials.govVisit source
- Reference 32FDAfda.govVisit source
- Reference 33RAREDISEASESrarediseases.info.nih.govVisit source
- Reference 34APPLIEDCLINICALTRIALSONLINEappliedclinicaltrialsonline.comVisit source
- Reference 35MEDIDATAmedidata.comVisit source
- Reference 36NEJMnejm.orgVisit source
- Reference 37IQVIAiqvia.comVisit source
- Reference 38ASCOPUBSascopubs.orgVisit source
- Reference 39CLINICALLEADERclinicalleader.comVisit source
- Reference 40ALZFORUMalzforum.orgVisit source
- Reference 41NATUREnature.comVisit source
- Reference 42ASGCTasgct.orgVisit source
- Reference 43CENTERWATCHcenterwatch.comVisit source
- Reference 44ECec.europa.euVisit source
- Reference 45GABIONLINEgabionline.netVisit source
- Reference 46ACCacc.orgVisit source
- Reference 47ARDard.bmj.comVisit source
- Reference 48IAVIiavi.orgVisit source
- Reference 49PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 50SCIMAGOJRscimagojr.comVisit source
- Reference 51THELANCETthelancet.comVisit source
- Reference 52DOAJdoaj.orgVisit source
- Reference 53CLARIVATEclarivate.comVisit source
- Reference 54JAMANETWORKjamanetwork.comVisit source
- Reference 55MEDRXIVmedrxiv.orgVisit source
- Reference 56BMJbmj.comVisit source
- Reference 57JOURNALSjournals.plos.orgVisit source
- Reference 58CELLcell.comVisit source
- Reference 59SCIENCEscience.orgVisit source
- Reference 60ANNUALREVIEWSannualreviews.orgVisit source
- Reference 61RETRACTIONWATCHretractionwatch.comVisit source
- Reference 62ALTMETRICaltmetric.comVisit source
- Reference 63COCHRANELIBRARYcochranelibrary.comVisit source
- Reference 64WOLTERSKLUWERwolterskluwer.comVisit source
- Reference 65SCHOLARscholar.google.comVisit source
- Reference 66SPRINGERNATUREspringernature.comVisit source
- Reference 67SCOPUSscopus.comVisit source
- Reference 68NCSESncses.nsf.govVisit source
- Reference 69REPORTERreporter.nih.govVisit source
- Reference 70ACRPNETacrpnet.orgVisit source
- Reference 71AMA-ASSNama-assn.orgVisit source
- Reference 72MARIE-SKLODOWSKA-CURIE-ACTIONSmarie-sklodowska-curie-actions.ec.europa.euVisit source
- Reference 73HEALTHCAREERShealthcareers.nhs.ukVisit source
- Reference 74NEXUSnexus.od.nih.govVisit source
- Reference 75IMSGLOBALimsglobal.comVisit source
- Reference 76AACNNURSINGaacnnursing.orgVisit source
- Reference 77USPTOuspto.govVisit source
- Reference 78JSPSjsps.go.jpVisit source
- Reference 79PRIMRprimr.orgVisit source
- Reference 80LINKEDINlinkedin.comVisit source
- Reference 81VAva.govVisit source
- Reference 82ACPEacpe.orgVisit source
- Reference 83AAPMaapm.orgVisit source
- Reference 84BLSbls.govVisit source
- Reference 85UNAIDSunaids.orgVisit source
- Reference 86CANCERcancer.orgVisit source
- Reference 87ALZalz.orgVisit source
- Reference 88CDCcdc.govVisit source
- Reference 89GENOMEgenome.govVisit source
- Reference 90NIDAnida.nih.govVisit source